NCT01420289
Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD
Sponsored by Calvary Hospital, Bronx, NY
To evaluate the effects of HPIPC for the treatment of symptoms of PAD
Inclusion Criteria: * Intermittent claudication \>6mo * Ischemic ulceration or ulcer of mixed (venous) etiology * ABI \< 0.7 * Ambulatory * Able to comply Exclusion Criteria: * Gangrene * M.I. within 6mo * Inability to walk * Wound infection * Systemic corticosteroids * HBO, Apligraf, Dermagraft within 6mo * Falsely elevated ankle to brachial index (ABI) * Inflammatory condition affecting healing
Center for Curative and Palliative wound Care, Calvary Hospital
The Bronx, New York, United States
Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.
Interested in this trial?
Express your interest and we'll connect you with the trial team.
Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.
Conditions